FLT3 and acute myeloid leukemia: As reported by Masciarelli et al., a combination therapy consisting of low concentrations of retinoic acid, tunicamycin, and arsenic trioxide can induce oxidative stress and ER stress, resulting in FLT3-ITD-mutated AML cells’ apoptosis.